Company profile: Quotient Sciences
1.1 - Company Overview
Company description
- Provider of formulation development, clinical pharmacology, and clinical-to-commercial manufacturing. Services span preformulation; small-batch supply to accelerate POC; 14-day make-test cycles in humans; process development and scale-up through Phase II/III; commercial manufacturing for ANDA/NDA/MAA/Japanese NDA; and Translational Pharmaceutics integrating formulation, adaptive GMP manufacturing, and clinical research.
Products and services
- Translational Pharmaceutics: A GMP-compliant platform integrating formulation development, real-time adaptive manufacturing, and clinical research to shorten development times by unifying drug development and clinical testing
- Formulation Optimization and Validation of Product Performance in Humans: Adaptive integration of real-time manufacturing with clinical testing, developing formulations from human data via 14-day make-test cycles to verify performance rapidly
- Clinical Development and Accelerating to Proof-of-Concept (POC): Small-batch capability offering manufacturing and supply services that conserve API, enable dose flexibility, and deliver personalized manufacturing to speed early clinical proof-of-concept.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Quotient Sciences
Pharmia
HQ: Finland
Website
- Description: Provider of nutritional supplements and healthcare supplies, developing and manufacturing products and specializing in product development. The company continually innovates, researches, and develops new compositions, flavors, and product applications, serving companies that market food supplements in Finland.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pharmia company profile →
Synerlab
HQ: France
Website
- Description: Provider of contract development and manufacturing for medicinal products (human and veterinary), medical devices and food supplements, from product development to manufacturing and packaging across solid and semi-solid forms and non-sterile/sterile liquids. Services include formulation, galenics, analytics, clinical batches (phase 1–3), production of oral solids, non-sterile monodose, sterile multidose (nasal/eye/ear drops), and freeze drying, including biomolecular drugs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synerlab company profile →
Lindus Health
HQ: United Kingdom
Website
- Description: Provider of end-to-end clinical trial services for the life sciences sector, covering ethics/IRB submissions, trial monitoring, data management, biostatistics, regulatory and payor affairs; AI-assisted trial design; direct patient recruitment; a clinical software platform (EDC, eSource, CTMS); CDISC SDTM data delivery; site and feasibility capabilities; and patient concierge support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lindus Health company profile →
Meridien Research
HQ: United States
Website
- Description: Provider of opportunities for patients and families to participate in clinical research trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Meridien Research company profile →
PharmaCell
HQ: The Netherlands
Website
- Description: Provider of GMP-certified cell-culturing and contract manufacturing services for cellular therapies and regenerative medicine in Europe, operating facilities in Maastricht and Geleen. Serves world-leading commercial cell therapy companies and offers support or partnership to R&D companies through an extensive network.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PharmaCell company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Quotient Sciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Quotient Sciences
2.2 - Growth funds investing in similar companies to Quotient Sciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Quotient Sciences
4.2 - Public trading comparable groups for Quotient Sciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →